Related Experiment Video
Updated: Jan 7, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
A CT-based interpretable machine learning model for preoperative prediction of pancreatic neuroendocrine tumor
Rong Kong1, Shunzu Lu1, Yugui Huang1
1Department of Radiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Objectives:
This study aimed to develop and validate an interpretable machine learning (ML) model based on structured preoperative CT features for non-invasive prediction of pancreatic neuroendocrine Tumors (PNETs) aggressiveness.
Methods:
This retrospective study included 112 patients with PNETs who underwent contrast-enhanced abdominal CT. Patients were randomly assigned to training and validation cohorts. Clinical data and CT features were analysed using the Least Absolute Shrinkage and Selection Operator method and multivariate logistic regression to identify independent risk factors. Multiple ML models were evaluated to determine the optimal classifier. Model performance was assessed using receiver operating characteristic and calibration curves, and decision curve analysis. Shapley Additive Explanations (SHAP) quantified feature importance for interpretable risk prediction.
Results:
A total of 112 patients were evaluated, including 80(mean age± standard deviation, 47 ± 13 years; 36 males)) in the training set and 32 (48 ± 15 years; 12 males) in the validation set. Tumour shape, necrotic changes, arterial relative enhancement ratio, and enhancement pattern independently predicted PNETs aggressiveness. The logistic regression model demonstrated excellent discrimination, achieving an area under the curve of 0.952 (95% CI: 0.952 (0.909-0.994) in the training cohort and 0.972 (95% CI 0.927-1.000) in the validation cohort. SHAP summary and force plots facilitated global and local model interpretation.
Conclusion:
The Interpretable ML model based on CT features could serve as a preoperative, noninvasive, and precise evaluation tool to differentiate aggressive and non-aggressive PNETs, facilitating personalized clinical management and potentially improving patient outcomes.
More Related Videos
06:24Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018